Maged Shenouda

RLMD

Maged Shenouda serves as officer: Chief Financial Officer at Relmada Therapeutics, Inc. (RLMD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

6 trades

$2.36M

Total Sells

1 trades

$354.5K

Net Position

Net Buyer

$2.01M

Companies Traded

RLMD

Active Period

Mar 2021 – Sep 2026

7 total trades

Most Recent

Buy RLMD

Sep 11, 2026 · $844.0K

Maged Shenouda's Insider Trading at Relmada Therapeutics, Inc. (RLMD)

Buys

6 · $2.36M

Sells

1 · $354.5K

Total Shares Bought

997,772

Total Shares Sold

10,000

RLMD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 11, 2026	Buy	200,000	$4.22	$844.0K	1,000,000
Dec 12, 2025	Buy	11,665	$4.12	$48.1K	0
Nov 5, 2025	Buy	500,000	$2.20	$1.10M	0
May 16, 2025	Buy	200,000	$0.49	$97.2K	0
Sep 11, 2024	Buy	53,432	$2.80	$149.7K	88,335
Jan 31, 2024	Buy	32,675	$3.85	$125.7K	34,903
Mar 10, 2021	Sell	10,000	$35.45	$354.5K	12,128

Related Insiders

TRAVERSA SERGIO

director, officer: Chief Executive Officer

RLMDBuy · Sep 11, 2026

Chuck Ence

CAO and COO

RLMDBuy · Nov 5, 2025

Paul Edward Kelly

Chief Operating Officer

RLMDBuy · Nov 5, 2025

Explore More Insider Trading Data

RLMD Insider Trading Activity

View all insider trades at Relmada Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity